- Home
- OLP vs BBNX Comparison
OLP vs BBNX Comparison
Compare OLP & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OLP | BBNX |
|---|---|---|
| Founded | 1982 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 550.9M | 493.1M |
| IPO Year | 1995 | 2025 |
Fundamental Metrics
Financial Performance| Metric | OLP | BBNX |
|---|---|---|
| Price | $23.94 | $19.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $26.75 | $23.80 |
| AVG Volume (30 Days) | 66.0K | ★ 960.2K |
| Earning Date | 05-05-2026 | 04-21-2026 |
| Dividend Yield | ★ 7.88% | N/A |
| EPS Growth | N/A | ★ 78.95 |
| EPS | ★ 1.00 | N/A |
| Revenue | $82,740,000.00 | ★ $100,251,000.00 |
| Revenue This Year | $11.98 | $34.90 |
| Revenue Next Year | $3.71 | $34.63 |
| P/E Ratio | $23.84 | ★ N/A |
| Revenue Growth | 1.02 | ★ 53.94 |
| 52 Week Low | $19.62 | $8.80 |
| 52 Week High | $25.88 | $32.71 |
Technical Indicators
Market Signals| Indicator | OLP | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 43.68 | 59.80 |
| Support Level | $23.31 | $9.34 |
| Resistance Level | $24.88 | $20.74 |
| Average True Range (ATR) | 0.43 | 1.05 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 18.60 | 63.55 |
Price Performance
Historical ComparisonAbout OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred and two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.